FDA Insights
Gaurav discusses the FDA's stringent testing standards and the importance of pricing life-saving therapies based on clinical benefits. He emphasizes the collaboration between companies and the FDA, highlighting the shared goal of finding solutions and the human aspect of regulators.In this clip
From this podcast
StarTalk Radio
Unlocking Gene Therapy with Neil deGrasse Tyson & Gaurav Shah
Related Questions